ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026
Asia Pacific Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents, Kits) by Applications (Diagnostics, Testing) by End Users (Hospitals and Diagnostic Laboratories, Research Institutes, Other End-users) & by Geography.
The Asia Pacific immunohistochemistry market is projected to rise at 8.18% of CAGR during the forecasting years. The base year considered for the market study is 2017 and the forecasting years are from 2018 to 2026. Rising cancer incidence and growing popularity of POC testing are advancing the market in the APAC region.
The immunohistochemistry market in Asia Pacific region is forecasted to evolve at the fastest growth rate. China, India, Japan, South Korea, Australia, and Rest of APAC are countries present in the Asia Pacific region. China is the most lucrative market for immunohistochemistry market. Academic research is on the constant upsurge in China which is bringing technological developments in the market. In addition, the Chinese government are taking well-funded & substantial precision medicine initiative to augment the growth of the market in the country. On the other hand, increasing geriatric dependence is the major factor for the growth of the market in India.
The top companies mentioned in the market report are Merck Millipore, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Danaher Corporation, Histologix, F. Hoffmann-La Roche Ag, Siemens Ag Healthcare, Bio Sb, Biogenex, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Abbott Laboratories, Abcam Plc, and Perkinelmer Inc.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- REAGENTS PRODUCTS ARE GROWING AT A SIGNIFICANT RATE
- DIAGNOSTICS IS MAJORLY USED APPLICATION IN THE MARKET
- HOSPITALS AND DIAGNOSTIC LABORATORIES HOLDS THE LARGEST SHARE IN THE END-USERS MARKET
- MARKET DETERMINANTS
- MARKET DRIVERS
- RISING CANCER INCIDENCE
- TECHNOLOGICAL EXPANSIONS IN IN-VITRO DIAGNOSTIC COMMERCE
- INCREASING HEALTHCARE SPENDING
- GROWING POPULARITY OF POC TESTING
- MARKET RESTRAINTS
- LIMITATIONS OF CLOSED SYSTEMS
- PRESENCE OF AN UNDIAGNOSED POPULATION
- MARKET OPPORTUNITIES
- USE OF BIOMARKERS FOR DISEASE DIAGNOSIS AND INCREASING EFFICIENCY
- PARADIGM SHIFT TOWARD PRECISION DIAGNOSIS THROUGH PERSONALIZED MEDICINE
- ADVANCEMENTS IN TECHNOLOGIES
- MARKET CHALLENGES
- HIGH INITIAL INVESTMENT AND MAINTENANCE COST
- STRINGENT REGULATION FOR APPROVAL OF DEVICES
- PRICING PRESSURE COUPLED WITH LACK OF PRODUCT DIFFERENTIATION
- MARKET DRIVERS
- MARKET SEGMENTATION
- MARKET BY PRODUCTS 2018-2026
- ANTIBODIES
- PRIMARY ANTIBODIES
- SECONDARY ANTIBODIES
- EQUIPMENT
- SLIDE STAINING SYSTEMS
- TISSUE MICROARRAYS
- TISSUE PROCESSING SYSTEMS
- SLIDE SCANNERS
- OTHER EQUIPMENT’S
- REAGENTS
- HISTOLOGICAL STAINS
- BLOCKING SERA AND REAGENTS
- CHROMOGENIC SUBSTRATES
- FIXATION REAGENTS
- STABILIZERS
- ORGANIC SOLVENTS
- PROTEOLYTIC ENZYMES
- DILUENTS
- KITS
- ANTIBODIES
- MARKET BY APPLICATIONS 2018-2026
- DIAGNOSTICS
- CANCER
- INFECTIOUS DISEASES
- CARDIOVASCULAR DISEASE
- AUTOIMMUNE DISEASES
- DIABETES MELLITUS
- NEPHROLOGICAL DISEASES
- DRUG TESTING
- DIAGNOSTICS
- MARKET BY END USERS 2018-2026
- HOSPITALS AND DIAGNOSTIC LABORATORIES
- RESEARCH INSTITUTES
- OTHER END USERS
- MARKET BY PRODUCTS 2018-2026
- KEY ANALYTICS
- IMMUNOHISTOCHEMISTRY ETYMOLOGY
- VALUE CHAIN ANALYSIS
- RAW MATERIAL SUPPLIERS
- MANUFACTURERS
- DISTRIBUTORS
- END-USERS
- OPPORTUNITY MATRIX
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- CHINA
- INDIA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF APAC
- ASIA-PACIFIC
- COMPANY PROFILES
- ABBOTT LABORATORIES
- COMPANY PROFILE
- PRODUCT PORTFOLIO
- SWOT ANALYSIS
- STRATEGIC INITIATIVES
- ABCAM PLC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- AGILENT TECHNOLOGIES, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BIOGENEX
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- BIO-RAD LABORATORIES, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- BIO SB
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- CELL SIGNALING TECHNOLOGY, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- DANAHER CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- HOFFMANN-LA ROCHE AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS:
- STRATEGIC INITIATIVES
- HISTOLOGIX
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- MERCK MILLIPORE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- PERKINELMER, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SIEMENS AG HEALTHCARE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SWOT ANALYSIS
- STRATEGIC INITIATIVES
- THERMO FISHER SCIENTIFIC INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- ABBOTT LABORATORIES
TABLE LIST
TABLE 1 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT
TABLE 3 POPULATION AGED 60 YEARS AND ABOVE
TABLE 4 POPULATION AGED 80 YEARS AND ABOVE
TABLE 5 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 6 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)
TABLE 7 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPES 2018-2026 ($ MILLION)
TABLE 8 ASIA PACIFIC ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2018-2026 ($ MILLION)
TABLE 9 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES
TABLE 10 ASIA PACIFIC ANTIBODIES MARKET IN SECONDARY ANTIBODIES GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 11 SECONDARY ANTIBODY SELECTION
TABLE 12 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)
TABLE 13 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2018-2026 ($ MILLION)
TABLE 14 ASIA PACIFIC EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2018-2026 ($ MILLION)
TABLE 15 ASIA PACIFIC EQUIPMENT MARKET IN TISSUE MICROARRAYS 2018-2026 ($ MILLION)
TABLE 16 ASIA PACIFIC EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2018-2026 ($ MILLION)
TABLE 17 ASIA PACIFIC EQUIPMENT MARKET IN SLIDE SCANNERS 2018-2026 ($ MILLION)
TABLE 18 ASIA PACIFIC EQUIPMENT MARKET IN OTHER EQUIPMENT’S 2018-2026 ($ MILLION)
TABLE 19 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
TABLE 20 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 21 ASIA PACIFIC REAGENTS MARKET IN HISTOLOGICAL STAINS 2018-2026 ($ MILLION)
TABLE 22 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 23 ASIA PACIFIC REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2018-2026 ($ MILLION)
TABLE 24 ASIA PACIFIC REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2018-2026 ($ MILLION)
TABLE 25 ASIA PACIFIC REAGENTS MARKET IN FIXATION REAGENTS 2018-2026 ($ MILLION)
TABLE 26 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS
TABLE 27 ASIA PACIFIC REAGENTS MARKET IN STABILIZERS 2018-2026 ($ MILLION)
TABLE 28 ASIA PACIFIC REAGENTS MARKET IN ORGANIC SOLVENTS 2018-2026 ($ MILLION)
TABLE 29 ASIA PACIFIC REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2018-2026 ($ MILLION)
TABLE 30 ASIA PACIFIC REAGENTS MARKET IN DILUENTS 2018-2026 ($ MILLION)
TABLE 31 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)
TABLE 32 KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION
TABLE 33 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2018-2026 ($ MILLION)
TABLE 34 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)
TABLE 35 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC BY TYPES 2018-2026 ($ MILLION)
TABLE 36 ASIA PACIFIC DIAGNOSTIC MARKET IN CANCER 2018-2026 ($ MILLION)
TABLE 37 ASIA PACIFIC DIAGNOSTIC MARKET IN INFECTIOUS DISEASES 2018-2026 ($ MILLION)
TABLE 38 ASIA PACIFIC DIAGNOSTIC MARKET IN CARDIOVASCULAR DISEASE 2018-2026 ($ MILLION)
TABLE 39 ASIA PACIFIC DIAGNOSTIC MARKET IN AUTOIMMUNE DISEASES 2018-2026 ($ MILLION)
TABLE 40 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES
TABLE 41 ASIA PACIFIC DIAGNOSTIC MARKET IN DIABETES MELLITUS 2018-2026 ($ MILLION)
TABLE 42 ASIA PACIFIC DIAGNOSTIC MARKET IN NEPHROLOGICAL DISEASES 2018-2026 ($ MILLION)
TABLE 43 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)
TABLE 44 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2018-2026 ($ MILLION)
TABLE 45 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)
TABLE 46 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)
TABLE 47 CANCER RESEARCH PROGRAM
TABLE 48 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)
TABLE 49 IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY
TABLE 50 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 51 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 52 CANCER TYPES BASED ON INCIDENCE RATES (2016)
TABLE 53 CANCER TYPES BASED ON MORTALITY RATES (2016)
TABLE 54 ESTIMATED INCIDENCE OF ALL CANCERS COMBINED BY SEX (2017)
TABLE 55 ESTIMATED COMMON CAUSES OF DEATH FOR CANCER (MALES 2017)
TABLE 56 ESTIMATED COMMON CAUSES OF DEATH FOR CANCER BY SEX (FEMALES 2017)
FIGURE LIST
FIGURE 1 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 2 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)
FIGURE 3 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)
FIGURE 4 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
FIGURE 5 PHASES OF HISTOLOGICAL STAINING
FIGURE 6 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)
FIGURE 7 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)
FIGURE 8 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)
FIGURE 9 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)
FIGURE 10 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)
FIGURE 11 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)
FIGURE 12 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 13 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 14 CHINA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 15 INDIA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 16 JAPAN IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 17 SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 18 AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 19 REST OF APAC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- CHINA
- INDIA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF APAC
- ASIA-PACIFIC
- MARKET SEGMENTATION
- MARKET BY PRODUCTS 2018-2026
- ANTIBODIES
- PRIMARY ANTIBODIES
- SECONDARY ANTIBODIES
- EQUIPMENT
- SLIDE STAINING SYSTEMS
- TISSUE MICROARRAYS
- TISSUE PROCESSING SYSTEMS
- SLIDE SCANNERS
- OTHER EQUIPMENT’S
- REAGENTS
- HISTOLOGICAL STAINS
- BLOCKING SERA AND REAGENTS
- CHROMOGENIC SUBSTRATES
- FIXATION REAGENTS
- STABILIZERS
- ORGANIC SOLVENTS
- PROTEOLYTIC ENZYMES
- DILUENTS
- KITS
- ANTIBODIES
- MARKET BY APPLICATIONS 2018-2026
- DIAGNOSTICS
- CANCER
- INFECTIOUS DISEASES
- CARDIOVASCULAR DISEASE
- AUTOIMMUNE DISEASES
- DIABETES MELLITUS
- NEPHROLOGICAL DISEASES
- DRUG TESTING
- DIAGNOSTICS
- MARKET BY END-USERS 2018-2026
- HOSPITALS AND DIAGNOSTIC LABORATORIES
- RESEARCH INSTITUTES
- OTHER END-USERS
- MARKET BY PRODUCTS 2018-2026
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.